-
Takeaways from Talking to 50 Parkinson's Experts
June 29, 2018
… Benjamin Stecher is taking an investigative approach to his own Parkinson's diagnosis. He writes in a new blog … Each has brought with it some profound new insights into how we work and what goes wrong as we age. They have also … (MJFF) advisors and grantees. MJFF CEO Todd Sherer, PhD, commented on the shift to understand and treat Parkinson's …
-
Investigating signaling pathway dysfunction linked to LRRK2
… thousands of cases of Parkinson’s disease, and are the most common genetic cause of this disease. At present we don’t understand what causes cells to die in the brains of people who have these mutations. … use cells and brain tissue from these patients to find out how the mutations alter the biology of LRRK2 with such …
-
19,341 Feet Closer to a Cure
September 8, 2017
… I first learned that I would be part of the Team Fox climb to Mount Kilimanjaro, I was overjoyed. For five minutes. As … the outdoors, I was ecstatic at the opportunity to marry my commitment for curing Parkinson’s disease (PD) with the … set in. I had to raise $10,000 and climb 19,341 feet! How do you even begin? The answer, I soon discovered, was …
-
Why Your Advocacy Is Key to Advancing Parkinson's Priorities
July 29, 2020
… importance of voicing your Parkinson’s priorities on Capitol Hill and how that might look different during a pandemic. Stepping … and mental health policy asks that could impact our community Interested in Parkinson’s advocacy? We need your …
-
Investigating the Role of LRRK2 in Immunity and Susceptibility to Infection
… Study Rationale: One of the most common inherited causes of Parkinson's disease (PD) is … or mutations, of the LRRK2 gene. Our previous studies have shown that immune cells called macrophages are unable to carry a normal immune response without LRRK2. We now aim …
-
Michael J. Fox Foundation for Parkinson’s Research Commits up to $2 Million to Visualize Alpha-Synuclein Protein in the Brain
June 3, 2008
… Michael J. Fox Foundation for Parkinson’s Research is committing up to $2 million to develop and test non-invasive imaging … the field’s current intensive efforts to therapeutically target alpha-synuclein. “New approaches in the pipeline seek to …